|
Sign In to gain access to subscriptions and/or personal tools.
|
Renal graft failure after addition of an angiotensin II receptor antagonist to an angiotensin-converting enzyme inhibitor: unmasking of an unknown iliac artery stenosis
Anne-Lise Kamper
Department of Nephrology, Herlev Hospital, ankam@ herlevhosp.kbhamt.dk
Arne Høj Nielsen
Department of Nephrology, Herlev Hospital
Niels Bækgaard
Department of Vascular Surgery, University of Copenhagen
Svend Just
Department of Radiology, Gentofte Hospital, University of Copenhagen, Denmark
Combined treatment with an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin II (Ang II) receptor blocker (ARB) has been suggested in order to achieve a more complete blockade of the renin-angiotensin-aldosterone system in cardiovascular and renal disease. The present report describes a case of acute renal graft dysfunction following the addition of an ARB to existing ACE inhibition. This unmasked an unknown iliac artery stenosis. The case indicates a possible important role of Ang II generated by non-ACE pathways in this situation.
Key Words: dual angiotensin II blockade renal artery stenosis renal graft dysfunction
References
- Kamper AL, Strandgaard S., Leyssac PP Effect of enalapril on the progression of chronic renal failure.A randomized controlled trial. Am J Hypertens 1992;5:423-30.[Web of Science][Medline]
[Order article via Infotrieve]
- Lewis EJ, Hunsicker LG, Bain RP, Rohde RD The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-62.[Abstract/Free Full Text]
- The GISEN Group: Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997;349:1857-63.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Weinberg MS, Weinberg AJ, Zappe DH Effectively target-ting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors. JRAAS 2000;1:217-33.[Medline]
[Order article via Infotrieve]
- Hricik DE, Browning PJ, Koppelmann R., Goorno WE, Madias NE, Dzan J. Captopri-linduced functional renal insufficiency in patients with bilateral renal artery-stenosis or renal-artery stenosis in a solitary kidney. N Engl J Med 1983;308:373-6.[Web of Science][Medline]
[Order article via Infotrieve]
- Wenting GJ,Tan-tjiong HL, Derkx FHM, de Bruyn JHB, Man int Veld AJ, Schelenkeamp MADH. Split renal function in unilateral renal artery stenosis. BMJ 1984;288:886-90.[Abstract/Free Full Text]
- Cohn JN,Tognoni G. A randomized trial of the angiotensin receptor blocker valsartan in chronic heart failure. N Engl J Med 2001;345:1667-75.[Abstract/Free Full Text]
- Mogensen CE, Neldam S.,Tikkanen I. et al. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ 2000;321:1440-4.[Abstract/Free Full Text]
- Russo D., Pisani A., Balletta MM et al. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis 1999;33:851-6.[Web of Science][Medline]
[Order article via Infotrieve]
- Elung-Jensen T., Heisterberg J., Kamper AL High serum enalaprilat in chronic renal failure. JRAAS 2001;2:240-5.[Medline]
[Order article via Infotrieve]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 3, No. 2,
135-137 (2002)
DOI: 10.3317/jraas.2002.016

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|